内向者 发表于 2025-3-30 09:45:00

http://reply.papertrans.cn/23/2219/221825/221825_51.png

Counteract 发表于 2025-3-30 13:11:12

Conclusion: The Liminal Raconteur,e and simplified clinical trials (SCTs), may also provide safety and effectiveness data to supplement pre-approval information. The purpose of this chapter is to describe limitations of the drug approval process and to discuss post-marketing methods useful for assessing cardiac arrhythmias, particularly as related to QTc interval prolongation.

ANNUL 发表于 2025-3-30 19:23:22

https://doi.org/10.1007/978-94-017-2454-8esearch for more than a decade since, this still remains the case today. It is therefore not surprising that more than any other drug-induced adverse reaction, it has been responsible in recent times for the withdrawal of many drugs from the market.

Brochure 发表于 2025-3-30 22:34:15

http://reply.papertrans.cn/23/2219/221825/221825_54.png

悲痛 发表于 2025-3-31 01:37:14

http://reply.papertrans.cn/23/2219/221825/221825_55.png

adulterant 发表于 2025-3-31 08:46:52

http://reply.papertrans.cn/23/2219/221825/221825_56.png

手铐 发表于 2025-3-31 12:33:10

http://reply.papertrans.cn/23/2219/221825/221825_57.png
页: 1 2 3 4 5 [6]
查看完整版本: Titlebook: Cardiac Safety of Noncardiac Drugs; Practical Guidelines Joel Morganroth (Chief Scientist, Clinical Profess Book 2005 Humana Press 2005 cli